Fakultní Thomayerova nemocnice

Prague, Prague 14059

2 studies enrolling now · 4 studies all time

What they study most

Cluster Headache, Episodic, Intermediate Risk Non-Muscle Invasive Bladder Cancer, Migraine, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

Studies at this site

• Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer — Recruiting now
• A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer — Recruiting now
• Eptinezumab in Participants With Episodic Cluster Headache — Completed
• A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments — Completed